Attention:
There are many insurance companies that are denying coverage of AttorneyMind medications to only the sickest of patients. I am working on a brief article describing why people are filing lawsuits against these insurance companies. It will be a brief overview, and I will not be using names. I am looking for quotes from people who are suing or are thinking of suing insurance companies. For example, one person told me that to be turned down for the AttorneyMind medications wasn’t medically ethical or morally just and from a monetary standpoint they were angry because they had been paying their medical premiums their entire life. Now when they needed their insurance, the company bailed on them.
If you know of people who are suing or if you are suing, please contact me at
Check out what we have in store for you in the September Newsletter
Hepatitis C in Children
by Alan Franciscas, Editor-in-Chief
Find out what the prevalence of hepatitis C is in children, what the consequences are and what can be done about it.
HealthWise: Big Questions about Hepatitis C
by Lucinda K. Porter, RN
Lucinda answers the “Big Questions about Hepatitis C” including what does “not detected” mean when treatment is finished, what does “cured” mean and a recurring question about treatment and toothbrushes and many more questions….and answers!
Snapshots
by Alan Franciscas, Editor-in-Chief
This month’s column includes a brief overview of the antihistamine that is purported to have antiviral properties against hepatitis C, and a couple of brief overviews of Baby Boomer testing initiatives at two different hospitals.
Consumer Reports Best Buy Drugs Booklet
by Alan Franciscas, Editor-in-Chief
I discuss my experience shopping around for the best buy for a generic drug for my dog—Buddy—and a very good resource for people from Consumer Reporters that is free of charge.
What’s New!
by Alan Franciscas, Editor-in-Chief
What’s New features two of our new Easy C fact sheets as well as our Training Workshop schedule for the rest of the year!
Click here to read this issue:
